A Randomised Trial of Expedited Transfer to a Cardiac Arrest Centre for Non-ST Elevation Out-of-hospital Cardiac Arrest (ARREST)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03872960 |
Recruitment Status :
Recruiting
First Posted : March 13, 2019
Last Update Posted : March 13, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Out-Of-Hospital Cardiac Arrest | Procedure: Transfer to cardiac arrest centre | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 860 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | A Randomised Trial of Expedited Transfer to a Cardiac Arrest Centre for Non-ST Elevation Out-of-hospital Cardiac Arrest |
Actual Study Start Date : | February 2, 2018 |
Estimated Primary Completion Date : | November 30, 2021 |
Estimated Study Completion Date : | April 20, 2022 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention Arm: Expedited transfer to a CAC
The intervention arm consists of activation of the pre-hospital triaging system currently in place for post-arrest STE patients. This involves pre-alert of the CAC and strategic delivery of the patient to the catheter laboratory (24 hours a day, 7 days a week). Patients will receive definitive post-resuscitation care: intubation and ventilation, where necessary, targeted temperature management, and goal directed therapies including evaluation and identification of underlying cause of arrest with access to immediate reperfusion if necessary. Prognostication will occur no earlier than 72 hours post-cardiac arrest to prevent premature withdrawal of life-sustaining treatment. Transfer times estimated from the 40-patient pilot are anticipated to be 100 minutes (median; IQR 75 to 113) from time of arrest to the designated centre.
|
Procedure: Transfer to cardiac arrest centre
Patients in the intervention arm will be taken directly to a the catheter lab of a heart attack centre. |
No Intervention: Control Arm: Current standard of care
The control arm comprises the current standard of pre-hospital advanced life support (ALS) care management for patients with ROSC following cardiac arrest of suspected cardiac aetiology. The patient is conveyed to the geographically closest emergency department. Management thereafter will be as per standard hospital protocols however as in the intervention arm, prognostication is to be delayed in trial patients until at least 72 hours post arrest.
|
- All-cause mortality [ Time Frame: 30 days after randomisation ]
- Cerebral performance category score [ Time Frame: Discharge (capped at 30 days) ]Neurological status assessed using the cerebral performance category (ranked scale from 1 to 5 with 1 being the best outcome and 5 the worse outcome)
- Modified Rankin Score [ Time Frame: Discharge (capped at 30 days) ]Neurological status assessed using the modified Ranking Score (ranked scale from 0 to 6 with 0 being the better outcome and 6 the worse outcome).
- Cerebral performance category score [ Time Frame: 3 months after randomisation ]Neurological assessed using the cerebral performance category (ranked scale from 1 to 5 with 1 being the best outcome and 5 the worse outcome)
- Modified Rankin Score [ Time Frame: 3 months after randomisation ]Neurological status assessed using the modified Ranking Score (ranked scale from 0 to 6 with 0 being the better outcome and 6 the worse outcome).
- All-cause mortality [ Time Frame: 3 months after randomisation ]
- All-cause mortality [ Time Frame: 6 months after randomisation ]
- All-cause mortality [ Time Frame: 12 months after randomisation ]
- Patient's quality of life [ Time Frame: Discharge (capped at 30 days) ]Assessed using the EuroQol-5 Dimension-5 Level (EQ-5D-5L) standardised survey

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Out-of-hospital cardiac arrest (OHCA)
- Return of spontaneous circulation (ROSC)
- Age 18 or over (known or presumed)
- Absence of non-cardiac cause (for example; trauma, drowning, suicide, drug overdose)
Exclusion Criteria:
- Criteria for ST-elevation myocardial infarction on 12-Lead electrocardiogram (ECG)
- Do Not Attempt Resuscitation (DNAR) Order
- Cardiac arrest suffered after care pathway set and patient en route
- Suspected pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03872960
Contact: Alexander D Perkins, MSc | +44 020 7927 2723 | alexander.perkins@lshtm.ac.uk | |
Contact: Tiffany Patterson, MBBS, PhD | tiffanypatterson05@gmail.com |
United Kingdom | |
Dartford and Gravesham NHS Trust | Active, not recruiting |
Dartford, United Kingdom | |
Barts Health NHS Trust | Active, not recruiting |
London, United Kingdom | |
BHR University Hospitals NHS Trust | Active, not recruiting |
London, United Kingdom | |
Chelsea and Westminster Hospital NHS Foundation Trust | Active, not recruiting |
London, United Kingdom | |
Croydon Health Services NHS Trust | Active, not recruiting |
London, United Kingdom | |
Epsom and St Helier University Hospitals NHS Trust | Active, not recruiting |
London, United Kingdom | |
Guy's and St Thomas' NHS FT | Active, not recruiting |
London, United Kingdom | |
Hillingdon Hospitals NHS Trust | Active, not recruiting |
London, United Kingdom | |
Homerton University Hospital NHS Trust | Active, not recruiting |
London, United Kingdom | |
Imperial College Healthcare NHS Trust | Active, not recruiting |
London, United Kingdom | |
King's College Hospital NHS Foundation Trust | Active, not recruiting |
London, United Kingdom | |
Kingston Hospital NHS FT | Active, not recruiting |
London, United Kingdom | |
Lewisham & Greenwich NHS Trust | Active, not recruiting |
London, United Kingdom | |
London Ambulance Service NHS Trust | Recruiting |
London, United Kingdom | |
Contact: Adam Smith | |
Principal Investigator: Mark Whitbread | |
London North West University Healthcare | Active, not recruiting |
London, United Kingdom | |
North Middlesex University Hospital NHS Trust | Active, not recruiting |
London, United Kingdom | |
Royal Brompton and Harefield NHS Trust | Active, not recruiting |
London, United Kingdom | |
Royal Free London NHS Foundation Trust | Active, not recruiting |
London, United Kingdom | |
St George's University Hospitals NHS Foundation Trust | Active, not recruiting |
London, United Kingdom | |
Surrey and Sussex Healthcare NHS Trust | Active, not recruiting |
London, United Kingdom | |
University College London Hospitals NHS Foundation Trust | Active, not recruiting |
London, United Kingdom | |
West Hertfordshire Hospitals NHS Trust | Active, not recruiting |
Watford, United Kingdom |
Principal Investigator: | Simon Redwood, MBBS, PhD | Guy's and St Thomas' NHS Foundation Trust |
Additional Information:
Publications:
Responsible Party: | Guy's and St Thomas' NHS Foundation Trust |
ClinicalTrials.gov Identifier: | NCT03872960 History of Changes |
Other Study ID Numbers: |
MJKTUAR ISRCTN96585404 ( Registry Identifier: ISRCTN ) |
First Posted: | March 13, 2019 Key Record Dates |
Last Update Posted: | March 13, 2019 |
Last Verified: | March 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
cardiac arrest pre-hospital care strategy trial |
Heart Arrest Out-of-Hospital Cardiac Arrest Heart Diseases Cardiovascular Diseases |